ORENCIA 125 MG

Generic Name/API: abatacept

Manufacturer: Bristol-Myers Squibb

Dosage Forms & Strength & Pack Size:
What ORENCIA contains
ORENCIA 50 mg solution for injection in pre-filled syringe
The active substance is abatacept.
Each pre-filled syringe contains 50 mg of abatacept in 0.4 mL.
ORENCIA 87.5 mg solution for injection in pre-filled syringe

The active substance is abatacept.
Each pre-filled syringe contains 87.5 mg of abatacept in 0.7 mL.
ORENCIA 125 mg solution for injection in pre-filled syringe

The active substance is abatacept.

Each pre-filled syringe contains 125 mg of abatacept in one mL.

The other ingredients are sucrose, poloxamer 188, sodium dihydrogen phosphate monohydrate,
disodium phosphate anhydrous, and water for injections (see section 2 “ORENCIA contains
sodium”).

Storage:
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the label and the carton after EXP.
The expiry date refers to the last day of that month.
Store in a refrigerator (2°C to 8°C). Do not freeze.
Store in the original package in order to protect from light.
Do not use this medicine if the liquid is cloudy or discoloured, or has large particles. The liquid should be clear to pale yellow.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to
throw away medicines you no longer use. These measures will help to protect the environment.

  • INDICATION
  • IMPORTANT SAFETY INFORMATION

What is ORENCIA?
ORENCIA is a prescription medicine that reduces signs and symptoms in:
• adults with moderate to severe rheumatoid arthritis (RA), including those who have not been helped enough by
other medicines for RA. ORENCIA may prevent further damage to your bones and joints and may help your ability
to perform daily activities. In adults, ORENCIA may be used alone or with other RA treatments other than tumor
necrosis factor (TNF) antagonists.
• people 2 years of age and older with moderate to severe polyarticular juvenile idiopathic arthritis (pJIA). ORENCIA
may be used alone or with methotrexate.
• people 2 years of age and older with active psoriatic arthritis (PsA). In adults, ORENCIA can be used alone or with
other PsA treatments. In children, ORENCIA can be used alone or with methotrexate.
ORENCIA is also used for the preventative treatment of acute graft versus host disease (aGVHD), in combination with
a calcineurin inhibitor and methotrexate, in:
• people 2 years of age and older undergoing hematopoietic stem cell transplantation (HSCT) from a matched or 1
allele-mismatched unrelated-donor.
It is not known if ORENCIA is safe and effective in children less than two years of age for the treatment of pJIA.
It is not known if ORENCIA is safe and effective in children less than two years of age for the treatment of PsA.
It is not known if ORENCIA is safe and effective in children less than two years of age for the preventative treatment of
aGVHD

Warnings and precautions
Talk to your doctor, pharmacist or nurse:






if you experience allergic reactions such as chest tightness, wheezing, severe dizziness or
lightheadedness, swelling or skin rash tell your doctor immediately.
if you have any kind of infection, including long-term or localised infection, if you often get
infections or if you have symptoms of infection (e.g. fever, malaise, dental problems), it is
important to tell your doctor. ORENCIA can lower your body’s ability to fight infection and
the treatment can make you more likely to get infections or make any infection you have worse.
if you have had tuberculosis (TB) or have symptoms of tuberculosis (persistent cough, weight
loss, listlessness, mild fever) tell your doctor. Before you use ORENCIA, your doctor will
examine you for tuberculosis or do a skin test.
if you have viral hepatitis tell your doctor. Before you use ORENCIA, your doctor may
examine you for hepatitis.
if you have cancer, your doctor will decide if you can still be given ORENCIA.
if you recently had a vaccination or are planning to have one, tell your doctor. Some vaccines
should not be given while you are receiving ORENCIA. Check with your doctor before you
are given any vaccines. Certain vaccinations may cause infections from the vaccine. If you
received ORENCIA while you were pregnant, your baby may be at a higher risk for getting
such an infection for up to approximately 14 weeks after the last dose you received during
pregnancy. It is important that you tell your baby’s doctors and other health care professionals
about your ORENCIA use during your pregnancy so they can decide when your baby should
receive any vaccine.

Diarrhea, nausea, and vomiting. Your doctor may recommend that you drink fluids or take medicine to treat these side effects. Tell your doctor if you have these symptoms, if they do not go away, or get worse, and if you are taking over-the-counter laxatives, stool softeners, and other medicines or dietary supplements.

Heart attack. Symptoms of a heart problem may include chest pain or pressure, pain in your arms, back, neck, or jaw, or shortness of breath.

Stroke. Symptoms of a stroke may include numbness or weakness on one side of your body, trouble talking, headache, or dizziness.

Bleeding problems. OFEV may increase your chances of having bleeding problems. Tell your doctor if you have unusual bleeding, bruising, wounds that do not heal, and/or if you are taking a blood thinner, including prescription blood thinners and over-the-counter aspirin.

Tear in your stomach or intestinal wall (perforation). OFEV may increase your chances of having a tear in your stomach or intestinal wall. Tell your doctor if you have pain or swelling in your stomach area.

Increased protein in your urine (proteinuria). OFEV may increase your chances of having protein in your urine. Tell your doctor if you have any signs and symptoms of protein in the urine such as foamy urine, swelling, including in your hands, arms, legs, or feet, or sudden weight gain.

The most common side effects of OFEV are diarrhea, nausea, stomach pain, vomiting, liver problems, decreased appetite, headache, weight loss, and high blood pressure.

These are not all the possible side effects of OFEV. For more information, ask your doctor or pharmacist.

 

Your doctor may also do tests to examine your blood values.
Children and adolescents
ORENCIA solution for injection in pre-filled syringe has not been studied in children and adolescents
under 2 years of age. Therefore, ORENCIA solution for injection in pre-filled syringe is not
recommended for use in this patient population.
Other medicines and ORENCIA
Tell your doctor if you are taking, have recently taken or might take any other medicines.
ORENCIA should not be used with biological medicines for rheumatoid arthritis, including TNF
blockers like adalimumab, etanercept, and infliximab; there is not enough evidence to recommend its
being given with anakinra and rituximab.
ORENCIA can be used with other medicines commonly used to treat rheumatoid arthritis, such as
steroids or painkillers, including non-steroidal anti-inflammatories such as ibuprofen or diclofenac.
Ask your doctor or pharmacist for advice before taking any other medicine while using ORENCIA.
Pregnancy and breast-feeding
The effects of ORENCIA in pregnancy are not known, so do not use ORENCIA if you are pregnant
unless your doctor specifically recommends it.


if you are a woman who could become pregnant, you must use reliable contraception (birth
control) while using ORENCIA and up to 14 weeks after the last dose. Your doctor will advise
you on suitable methods.
if you become pregnant while using ORENCIA, tell your doctor.
If you received ORENCIA during your pregnancy, your baby may have a higher risk for getting an
infection. It is important that you tell your baby’s doctors and other health care professionals about
your ORENCIA use during your pregnancy before the baby receives any vaccine (for more
information see section on vaccination).
It is not known whether ORENCIA passes into human milk. You must stop breast-feeding if you are
being treated with ORENCIA and for up to 14 weeks after the last dose.
Driving and using machines
The use of ORENCIA is not expected to affect the ability to drive, cycle or use machines. However, if
you are feeling tired or unwell after receiving ORENCIA, you should not drive, cycle or operate any
machinery.
ORENCIA contains sodium
This medicine contains less than 1 mmol sodium (23 mg) per dose, that is to say essentially ‘sodium
free’.

*The contents of this site are for reference only. We do not offer drug procurement service. All information must not be used for any commercial purpose.

Scroll to Top